We enrolled 184 adult liver transplantation patients, excluding pediatric and second grafts. The 129 living donor and 55 deceased donor liver transplantations were divided into 2 groups: LCM (+); (n = 20) and LCM (鈭?; (n = 164).
There were no differences in the demographic features, such as gender and recipient age, original disease, Model for End-Stage Liver Disease score, donor type, number of human leukocyte antigen mismatches, and cold ischemia times. There were no hyperacute rejection episodes in the LCM (+) group. Also, posttransplant complications such as acute rejection episode, biliary complication, or hepatic artery thrombosis were not different. Acute rejection episodes occurred in 5.0%of the LCM (+) group and 15.2%of the LCM (鈭? group (P = .317). Bile duct complications after transplantation arose in 20.0%of the LCM (+) group and in 32.9%of the LCM (鈭? group (P = .312). The 2 groups showed no difference in graft survival rate analyzed by the Kaplan-Meier method according to LCM results.
Pretransplant LCM results were not associated with overall graft survival or acute rejection episodes in this study.